These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 28323525)

  • 1. The Impact of Pharmacotherapy on Substance Use in Adolescents With Attention-Deficit/Hyperactivity Disorder: Variations Across Subtypes.
    Upadhyay N; Chen H; Mgbere O; Bhatara VS; Aparasu RR
    Subst Use Misuse; 2017 Aug; 52(10):1266-1274. PubMed ID: 28323525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Attention Deficit Hyperactivity Disorder (ADHD) Subtypes, Co-Occurring Psychiatric Symptoms and Sexual Risk Behaviors among Adolescents Receiving Substance Abuse Treatment.
    Regan T; Tubman J
    Subst Use Misuse; 2020; 55(1):119-132. PubMed ID: 31502500
    [No Abstract]   [Full Text] [Related]  

  • 3. Health-related quality of life in children and adolescents who have a diagnosis of attention-deficit/hyperactivity disorder.
    Klassen AF; Miller A; Fine S
    Pediatrics; 2004 Nov; 114(5):e541-7. PubMed ID: 15520087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attention-deficit/hyperactivity disorder subtypes and substance use and use disorders in NESARC.
    De Alwis D; Lynskey MT; Reiersen AM; Agrawal A
    Addict Behav; 2014 Aug; 39(8):1278-85. PubMed ID: 24821471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subtype differences in adults with attention-deficit/hyperactivity disorder (ADHD) with regard to ADHD-symptoms, psychiatric comorbidity and psychosocial adjustment.
    Sobanski E; Brüggemann D; Alm B; Kern S; Philipsen A; Schmalzried H; Hesslinger B; Waschkowski H; Rietschel M
    Eur Psychiatry; 2008 Mar; 23(2):142-9. PubMed ID: 18024089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and psychiatric comorbidity of attention-deficit/hyperactivity disorder in an adolescent Finnish population.
    Smalley SL; McGough JJ; Moilanen IK; Loo SK; Taanila A; Ebeling H; Hurtig T; Kaakinen M; Humphrey LA; McCracken JT; Varilo T; Yang MH; Nelson SF; Peltonen L; Järvelin MR
    J Am Acad Child Adolesc Psychiatry; 2007 Dec; 46(12):1575-83. PubMed ID: 18030079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD.
    Biederman J
    J Clin Psychiatry; 2003; 64 Suppl 11():3-8. PubMed ID: 14529323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modafinil improves symptoms of attention-deficit/hyperactivity disorder across subtypes in children and adolescents.
    Biederman J; Pliszka SR
    J Pediatr; 2008 Mar; 152(3):394-9. PubMed ID: 18280848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychiatric comorbidity differences in clinic-referred children and adolescents with ADHD according to the subtypes and gender.
    Ghanizadeh A
    J Child Neurol; 2009 Jun; 24(6):679-84. PubMed ID: 19491114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age of Onset, Duration, and Type of Medication Therapy for Attention-Deficit/Hyperactivity Disorder and Substance Use During Adolescence: A Multi-Cohort National Study.
    McCabe SE; Dickinson K; West BT; Wilens TE
    J Am Acad Child Adolesc Psychiatry; 2016 Jun; 55(6):479-86. PubMed ID: 27238066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adolescents With Attention-Deficit/Hyperactivity Disorder: Adverse Behaviors and Comorbidity.
    Sultan RS; Liu SM; Hacker KA; Olfson M
    J Adolesc Health; 2021 Feb; 68(2):284-291. PubMed ID: 33541601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Substance Misuse and Family History of Substance Use Disorder on Delay Discounting in Adolescents and Young Adults with Attention-Deficit/Hyperactivity Disorder.
    Paraskevopoulou M; van Rooij D; Schene AH; Scheres APJ; Buitelaar JK; Schellekens AFA
    Eur Addict Res; 2020; 26(4-5):295-305. PubMed ID: 32659779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychiatric comorbidity in Korean children and adolescents with attention-deficit hyperactivity disorder: psychopathology according to subtype.
    Byun H; Yang J; Lee M; Jang W; Yang JW; Kim JH; Hong SD; Joung YS
    Yonsei Med J; 2006 Feb; 47(1):113-21. PubMed ID: 16502492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comorbidity in adults with attention-deficit hyperactivity disorder.
    Cumyn L; French L; Hechtman L
    Can J Psychiatry; 2009 Oct; 54(10):673-83. PubMed ID: 19835674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse.
    Horner BR; Scheibe KE
    J Am Acad Child Adolesc Psychiatry; 1997 Jan; 36(1):30-6. PubMed ID: 9000778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between attention-deficit/hyperactivity disorder and sleep impairment in adulthood: evidence from a large controlled study.
    Surman CB; Adamson JJ; Petty C; Biederman J; Kenealy DC; Levine M; Mick E; Faraone SV
    J Clin Psychiatry; 2009 Nov; 70(11):1523-9. PubMed ID: 19646365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance use disorders in adolescents with attention deficit hyperactivity disorder: a 4-year follow-up study.
    Groenman AP; Oosterlaan J; Rommelse N; Franke B; Roeyers H; Oades RD; Sergeant JA; Buitelaar JK; Faraone SV
    Addiction; 2013 Aug; 108(8):1503-11. PubMed ID: 23506232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of gender on attention deficit hyperactivity disorder in children referred to a psychiatric clinic.
    Biederman J; Mick E; Faraone SV; Braaten E; Doyle A; Spencer T; Wilens TE; Frazier E; Johnson MA
    Am J Psychiatry; 2002 Jan; 159(1):36-42. PubMed ID: 11772687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of prior stimulant treatment for attention-deficit/hyperactivity disorder on subsequent risk for cigarette smoking and alcohol and drug use disorders in adolescents.
    Wilens TE; Adamson J; Monuteaux MC; Faraone SV; Schillinger M; Westerberg D; Biederman J
    Arch Pediatr Adolesc Med; 2008 Oct; 162(10):916-21. PubMed ID: 18838643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty-Year Trends in Diagnosed Attention-Deficit/Hyperactivity Disorder Among US Children and Adolescents, 1997-2016.
    Xu G; Strathearn L; Liu B; Yang B; Bao W
    JAMA Netw Open; 2018 Aug; 1(4):e181471. PubMed ID: 30646132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.